Cholestasis ; complications ; metabolism ; therapy ; Cholestasis, Intrahepatic ; etiology ; metabolism ; therapy ; Humans

Humans ; Liver Diseases, Alcoholic ; diagnosis ; etiology ; therapy

Animals ; Cell Death ; Hepatic Stellate Cells ; cytology ; Humans ; Liver Cirrhosis

Amino Acids ; metabolism ; Ammonia ; poisoning ; Hepatic Encephalopathy ; etiology ; Humans ; gamma-Aminobutyric Acid ; metabolism

Area Under Curve ; Biopsy ; Chronic Disease ; Confidence Intervals ; Elasticity Imaging Techniques ; Humans ; Liver ; pathology ; Liver Cirrhosis ; diagnosis ; pathology ; Predictive Value of Tests ; Sensitivity and Specificity ; Severity of Illness Index

Objective To investigate the impact of reduced glutathione(GSH) on the prolifera- tion,oxidative stress and transforming growth factor?1(TGF-?1) expression of human hepatocytes and hepatic stellate cells(HSCs)(LX-2 cell line).Methods Human hepatocytes and HSCs were incubated with various concentrations of GSH(0.5—50 mmol/L or 0.5—10 mmol/L).The effects of GSH on the proliferation of hepatocytes and HSCs were studied by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphennyhera- zolium bromide colorimetric assay.Human hepatocytes and HSCs were co-cultured with GSH and ferric nitrilotriacetic acid,superoxide dismutase (SOD) activity and malondialdehyde (MDA) contents were detected.HSCs were incubated with high(5.0 mmol/L),media(2.5 mmol/L) and low (0.5 mmol/L) concentrations of GSH,the expressions of TGF-?1 mRNA and protein were detected by ELISA and real- time PCR.Results In concentration ranged from 2.5 to 10 mmol/L,the GSH could promote the pro- liferation of hepatocytes but no HSCs,significantly increased the activity of SOD and decrease the con- tents of MDA in hepatocytes and HSCs,and inhibited the expression of TGF-?1 in HSCs.Conclusions GSH can not only promote the proliferation of hepatocytes,but also protect hepatocytes and HSCs from oxidative stress,and inhibit the secretion of TGF-?1 in HSCs.GSH may play a role in hepatocellular protection,antioxidation and anti-fibrosis.

Humans ; Liver Cirrhosis

Biomarkers ; blood ; Biopsy, Needle ; Diagnosis, Differential ; Diagnostic Imaging ; methods ; Elasticity Imaging Techniques ; Fatty Liver ; diagnosis ; epidemiology ; pathology ; Fatty Liver, Alcoholic ; diagnosis ; epidemiology ; pathology ; Hepatitis ; diagnosis ; Humans ; Liver ; diagnostic imaging ; pathology ; Liver Cirrhosis ; diagnosis ; epidemiology ; pathology ; Predictive Value of Tests ; Prognosis ; Sensitivity and Specificity ; Severity of Illness Index ; Tomography, X-Ray Computed

Cholangitis ; diagnosis ; etiology ; therapy ; Humans ; Immunoglobulin G ; metabolism

Diagnostic Imaging ; methods ; Humans ; Liver Cirrhosis ; diagnosis